Axil Capital leads $9.8m funding in Japanese biopharma Luca Science

Axil Capital leads $9.8m funding in Japanese biopharma Luca Science

Mars W. Mosqueda Jr.

03 September, 2020

axil capital Luca Science

Printed by Unregistered user on Sat, 20 Dec 2025 21:22:56 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese biopharma firm Waterstone raises $61m Series C round

S Korea's SK Biopharmaceuticals shares soar 30% in market debut

Read more from Rest of Asia

AnyMind Group to buy Japanese beauty distributor Sun Smile

Japan tender offers hit record $68b in 2025 as companies restructure